Browse stocks · Browse sectors · Healthcare · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

NSE RESEARCH WORKSPACE

Symbiotec Pharmalab Ltd

NSE: SYMBIOTEC

OverviewFinancial StatementsQuant ScoreForensic Accounting+

Price1Y

Company Overview

Symbiotec Pharmalab Ltd is classified in Pharmaceuticals.

Market Cap: ₹ 7,480.7 Cr.
Price in snapshot: ₹ 1,164.2
ROE: 11.2 %
ROCE: 12.83 %
Dividend Yield: -0 %

Snapshot updated 20 October 2026. Figures are not live quotes.

Research coverage

Concall documents: transcript for Q1 FY27, dated 28 September 2026.
Company exchange-filing catalog coverage.

Browse concall documents · Browse exchange filings